ミズーリ州における過体重の臨床試験
ミズーリ州内の拠点で、過体重に関する33件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Studymetrix Research /ID# 282163, City of Saint Peters
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
- Saint Louis University, St Louis
被験者募集中健康なボランティア歓迎
18歳〜35歳 · 全性別 · 2026/09/30更新 · NCT07849439AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- StudyMetrix Research LLC, City of Saint Peters
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Amicis Centers of Clinical Research, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Clinvest Headlands Llc, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Sundance Clinical Research, St Louis
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Washington University School of Medicine, St Louis
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington University School of Medicine, St Louis
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- StudyMetrix Research, City of Saint Peters
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
- 他1件
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Clinical Research Professionals, Chesterfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Clayton Sleep Institute - St. Louis - Tesson Ferry Road, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- StudyMetrix Research, City of Saint Peters
- Clinvest Headlands Llc, Springfield
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Clinical Research Professionals, Chesterfield
- Clinvest Headlands Llc, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Columbia
- AURORA-2 Clinical Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Kansas City VA Medical Center, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Clinvest Research LLC, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Chesterfield
- ACCOMPLISH-2 Research Site, City of Saint Peters
- ACCOMPLISH-2 Research Site, Hazelwood
- 他2件
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- StudyMetrix Research LLC, City of Saint Peters
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- StudyMetrix Research, City of Saint Peters
- Clinvest Headlands Llc, Springfield
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research - Kansas City, Kansas City
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research - Kansas City, Kansas City
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Jefferson City
- Research Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Clinvest Research, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Chesterfield
- ACCOMPLISH-1 Research Site, Hazelwood
- ACCOMPLISH-1 Research Site, St Louis
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Advancing Biopsychosocial Care Training Initiative
- Washington University School of Medicine, St Louis
被験者募集中健康なボランティア歓迎
5歳以上 · 全性別 · 2026/08/10更新 · NCT07049861Effects of Grape Consumption on the Immune-Gut Axis in Obesity
- University of Missouri-Columbia, Columbia
被験者募集中
18歳〜60歳 · 全性別 · 2026/07/31更新 · NCT07231484Effect of Ketone Esters on Liver Fat Content and Metabolic Function
- Washington University School of Medicine, St Louis
被験者募集中第2相健康なボランティア歓迎
18歳〜40歳 · 全性別 · 2026/07/15更新 · NCT07097506A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
- MBX Biosciences Investigational Site, Kansas City
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/06/09更新 · NCT07142707Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- Washington University School of Medicine, St Louis
被験者募集中観察研究健康なボランティア歓迎
12歳〜17歳 · 全性別 · 2025/12/18更新 · NCT05277558Social Determinants and a Diabetes Prevention Program Tailored for African Americans
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
被験者募集中第2相健康なボランティア歓迎
18歳以上 · 全性別 · 2025/05/25更新 · NCT05301413ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。